Document Detail

Cardiopulmonary exercise testing reveals onset of disease and response to treatment in a case of heritable pulmonary arterial hypertension.
MedLine Citation:
PMID:  23130108     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Patients affected by pulmonary arterial hypertension (PAH) show a typical pattern of abnormalities on cardiopulmonary exercise testing (CPET). However, CPET is not routinely used as a screening method. We discuss a patient with hereditary PAH in whom CPET revealed onset of disease. Furthermore, we show that the abnormalities observed can improve in part by PAH-specific treatment.
Pia Trip; Anton Vonk-Noordegraaf; Harm Jan Bogaard
Related Documents :
18811808 - Arrhythmic risk evaluation during exercise at high altitude in healthy subjects: role o...
3306868 - Diuretic therapy and exercise performance.
20964858 - Design and conduct of caudwell xtreme everest: an observational cohort study of variati...
11740628 - Historical and geological evidence for seismic origin of newly recognized landslides in...
8779948 - Progressive effect of endurance training on metabolic adaptations in working skeletal m...
12242198 - Spontaneous baroreflex sensitivity in young and older people during voluntary and elect...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Pulmonary circulation     Volume:  2     ISSN:  2045-8940     ISO Abbreviation:  Pulm Circ     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-11-06     Completed Date:  2012-12-12     Revised Date:  2014-03-18    
Medline Journal Info:
Nlm Unique ID:  101557243     Medline TA:  Pulm Circ     Country:  India    
Other Details:
Languages:  eng     Pagination:  387-9     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The renin-angiotensin system and right ventricular structure and function: The MESA-Right Ventricle ...
Next Document:  Takotsubo cardiomyopathy after treatment of pulmonary arterial hypertension.